Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Inventory (2020 - 2026)

Neuroone Medical Technologies filings provide 7 years of Inventory readings, the most recent being $1.9 million for Q1 2026.

  • On a quarterly basis, Inventory rose 94.63% to $1.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.9 million, a 94.63% increase, with the full-year FY2025 number at $2.2 million, up 153.89% from a year prior.
  • Inventory hit $1.9 million in Q1 2026 for Neuroone Medical Technologies, up from $1.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $2.2 million in Q3 2025 to a low of $221903.0 in Q1 2022.
  • Median Inventory over the past 5 years was $1.0 million (2025), compared with a mean of $1.2 million.
  • Biggest five-year swings in Inventory: skyrocketed 770.58% in 2022 and later crashed 55.76% in 2025.
  • Neuroone Medical Technologies' Inventory stood at $903554.0 in 2022, then surged by 78.04% to $1.6 million in 2023, then tumbled by 43.08% to $915641.0 in 2024, then increased by 10.6% to $1.0 million in 2025, then skyrocketed by 84.32% to $1.9 million in 2026.
  • The last three reported values for Inventory were $1.9 million (Q1 2026), $1.0 million (Q4 2025), and $2.2 million (Q3 2025) per Business Quant data.